- David Beckham invests in Prenetics, co-founds health brand IM8.
- Partnership aims to innovate in wellness industry.
- Prenetics expands portfolio, focusing on early cancer detection and genomic profiling technologies.
Former football superstar David Beckham has become a strategic investor in Prenetics, a Hong Kong-based health sciences company listed on NASDAQ.
The partnership will see Beckham co-found IM8, a new health and wellness brand focused on cutting-edge consumer health products.
This collaboration aims to leverage Beckham’s global influence and Prenetics’ scientific expertise to innovate in the health and wellness industry.
Golden boots meet lab coats
Prenetics CEO Danny Yeung expressed excitement about the partnership, highlighting Beckham’s alignment with the company’s core principles of discipline, teamwork, and health.
Beckham, who has had access to top medical professionals throughout his career, sees this venture as an opportunity to make advanced health and wellness accessible to a broader audience.
Tech tackles wellness
Beyond IM8, Prenetics is making waves in clinical health through its joint venture, Insighta, which focuses on multi-cancer early detection technologies.
The company’s portfolio also includes ACT Genomics, which has FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, offering next-generation sequencing DNA tests.
This partnership with Beckham marks a significant step in Prenetics’ mission to revolutionize global health and longevity.
